Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

11
Jessica Marshall staff
Jessica Marshall
Jessica Marshall is an associate at FasterCures.
Mar 14, 2022
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation article
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutt
ing-edge biomedical innovations to patients.
Nov 16, 2021
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials report
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials
FasterCures has initiated a body of work to advance system change within biomedical research to foc
us on and value diversity and representation within clinical trials.
Mar 25, 2022
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering&nbsp
;the market and can identify multiple cancers early and simultaneously.
Nov 3, 2021
Models for Financing Antibiotic Development to Address Antimicrobial Resistance report
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to id
Mar 24, 2022
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
Nov 19, 2021
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem report
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a n
ew treatment is safe and effective for human use.
Nov 18, 2021
Landscape of Trust: Health Data Frameworks report
Landscape of Trust: Health Data Frameworks
The rapid advancement of the health technology landscape relies heavily on patient data.
Mar 16, 2022
Milken Institute Outlines Next Steps for Mobilizing an Early Warning System for Pandemics article
Milken Institute Outlines Next Steps for Mobilizing an Early Warning System for Pandemics
Washington, DC, March 30, 2022—Recognizing the most effective way to combat the next pandemic is to
start planning for it now, FasterCures, a center of the Milken Institute, released key considerations and next steps for mobilizing an e
Mar 30, 2022
Milken Institute statement on ARPA-H inclusion in FY2022 spending bill article
Milken Institute statement on ARPA-H inclusion in FY2022 spending bill
Esther Krofah Executive Director Milken Institute FasterCures and Center for Public Health
Mar 14, 2022
2023-2026 National Health Security Strategy (NHSS) Comment Letter article
2023-2026 National Health Security Strategy (NHSS) Comment Letter
Submitted electronically Ms. Dawn O’Connell Assistant Secretary for Preparedness and Response HHS O
ffice of the Assistant Secretary for Preparedness and Response (ASPR) 200 Independence Ave. Washington, DC 20201
Mar 11, 2022